INTRODUCTION
Exercise in a hot environment challenges the function of cardiovascular (17) , metabolic (14) and thermoregulatory systems (24) ; thus exposure to prolonged, intense exercise that raises body temperature increases the risk of heat illness (1) and impairs athletic performance.
Subsequently, strategies have been designed to help athletes perform in hot environments, all of which are designed to regulate body temperature. A heat tolerance test is useful for assessing the ability to regulate body temperature and measurements of body temperature responses are integral to interpretation. Where improved heat tolerance is required, decisions regarding the most appropriate method and their specific derivatives are determined; these are usually grouped into 1) heat acclimation or acclimatization protocols and 2) cooling methods.
The most appropriate method is context specific but the choice is driven by whether body temperature responses to a strategy are sufficient to improve safety and performance.
Consequently it is important that practitioners use valid and reliable methods to monitor body temperature (6) to make well-informed and clear decisions about the success of the chosen method. Esophageal and rectal sites are most commonly used for assessing core body temperature (6, 30) ; however, ingestible telemetry pill systems that measure intestinal temperature are being increasingly used to overcome the impracticalities associated with traditional methods (5) . Several studies provide evidence to suggest that telemetry pill systems are valid tools for assessment of core temperature (13, 15, 16, 25, 26) ; however, there are little data regarding the reliability of intestinal temperature measurement during exercise in a hot environment.
Ingestible telemetry pills are often used when environmental temperature is high (≥25 °C) to monitor core body temperature or detect treatment effects following the application of an Reliability of intestinal temperature 4 intervention (e.g. cooling). For example, the reported magnitude of intestinal temperature change following a treatment in a hot environment ranges from 0.30 to 1.8 °C (27, 35) . As such, ingestible telemetry pill systems must demonstrate small test re-test error for practitioners to be confident that these changes are true and unlikely due to measurement error. Incorrect interpretation of intestinal temperature due to measurement error or failing to understand the limits of the system could place athletes at an increased risk of heat illness and impair athletic performance. To improve confidence when interpreting a change in a dependent variable it is important to identify the magnitude of measurement error within repeated measurements. Performing such an assessment assists in interpreting whether a change has occurred due to a treatment or because of inherent measurement error (biological or technical) and is also important for calculating sample size (3, 11, 20, 21 29) .
To date only two studies have published data regarding the inter-day test re-test reliability of intestinal pill telemetry systems. Goosey-Tolfrey et al. (18) conducted a small reliability study (n = 5) using ingestible telemetry pills (CorTemp, HQinc, USA) in wheelchair athletes exercising at submaximal intensities (50% peak power output (W peak ) for 60-min in a hot environment (30.8 °C, 60.1% relative humidity (RH)). The authors reported a mean testretest error of 0.30 °C (95% CI 0.20 -0.40) and limits of agreement (LOA 95%) of ± 1.2 °C.
In a cooler environment (15.0 °C, 60% RH), Gant et al. (16) investigated the reliability of telemetry pills (CorTemp, HQinc, USA) during intermittent shuttle running and reported excellent reliability with a near absent test-retest error of 0.01 °C (CI -0.02 -0.05 °C) and LOA 95% of ± 0.23 °C.
Given that ingestible telemetry pill systems are increasingly being used to monitor core body temperature responses and that important health, treatment-effect and performance decisions Reliability of intestinal temperature 5 are made upon these assessments, it is important to establish the test-re-test reliability of this method. The purpose of this study is to investigate the inter-day reliability of intestinal core temperature using an ingestible telemetry pill system during exercise within a hot environment.
METHODS

Experimental Approach to the Problem
Subjects were asked to visit the exercise physiology laboratory on three separate occasions.
Each visit was separated by a minimum of 3 days and maximum of 10 days. During visit 1, subjects performed an incremental exercise test to maximal volitional exertion for assessment of peak oxygen uptake ( O 2peak ) and associated power output (W peak ) at room temperature; (20 °C, 40% RH) followed by a 30-min exercise heat stress accustomisation trial within an environmental chamber (35 ˚C dry bulb temperature, 50% RH). During visits 2 and 3, subjects rested for 60 min in a temperature controlled environmental chamber set at 35 °C, 50% RH before cycling at a power output equivalent to 50% W peak for 60 min. The combination of environmental conditions and intensity of exercise was chosen to induce moderate to high heat strain within ethically acceptable limit of (39.5 ˚C intestinal temperature). All exercise trials were performed at the same time of day and at least 3 hours after waking and 3 hours before sleep to minimise the circadian rhythm impact on body temperature and gastrointestinal function (28) . All exercise trials were conducted using an externally-verified, electromagnetically-braked arm crank ergometer (Lode Angio, Groningen, The Netherlands) positioned for recumbent cycling.
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Subjects
Twelve non-heat-acclimated physically active males (age 25 ± 4 yrs, stature 181.7 ± 7.0 cm, body mass 81.1 ± 10.6 kg) volunteered for the study which was approved by the Ethics Committee of Sheffield Hallam University and conducted according to the principles of the Declaration of Helsinki. The risks and experimental procedures were fully explained and all subjects provided written informed consent before the study. Subjects were instructed to refrain from strenuous exercise, caffeine and alcohol 24 h before each trial and food 3 h before each trial. Each subject recorded their diet 24 h prior to the first heat stress trial and replicated their diet for the re-test. Adherence to the standardised diet was verified by the investigator prior to each trial. All experimental trials were conducted between the months of October and January in the UK, where mean maximum ambient temperatures ranged from 14 -7 °C).
Procedures: O 2peak test and accustomisation trial
Subjects undertook a 10-min warm-up period prior to physiological testing. Peak oxygen uptake ( O 2peak ) and associated power output (W peak ) were assessed using a continuous incremental exercise test to maximal volitional exertion. The initial intensity of exercise was set at 50 W and was increased by 25 W•min -1 in a stepped manner. Pedalling frequency was self-selected in the range of 60 -80 rev•min -1 , and subjects were encouraged to continue to maximal volitional exertion. Breath-by-breath pulmonary oxygen uptake was measured continuously using a calibrated low dead space (20 ml) bi-directional differential pressure pneumotach and rapid response galvanic O 2 and non-dispersive infrared CO 2 analysers
Reliability of intestinal temperature 7 (Ultima, CardiO 2 , Medgraphics, USA). Peak oxygen uptake was calculated as the highest 30 s average value recorded before termination of the test. The power output at the last completed stage was used to determine W peak . Heart rate was recorded continuously during exercise using short range telemetry (RS400, Polar OY, Finland).
After 60 min of rest in a temperate environment, subjects undertook 30 min of recumbent cycling within the environmental chamber (35 °C, 50% RH) at an intensity of 50% W peak to accustomise with the experimental procedures. Nude body mass (kg) was recorded before and after the accustomisation trial along with volume of water ingested ad libitum during the trial. Sweat rate (ml·min -1 ) was estimated from the change in body mass adjusted for fluid intake and urine output. Fluid requirements (which matched sweat rate) were calculated for each subject and were closely adhered to in the main experimental trials. During the exercise session heart rate, rating of perceived exertion (RPE) and thermal perception (TP) (3) were assessed every 5 min.
Heat stress trials 1 and 2
These sessions were used to assess the reliability of intestinal temperature measurements.
Subjects were instructed to replicate their diet 24 hours prior to each trial and consume 500 ml of non-caffeinated fluid in the preceding 2 hours to promote euhydration (2). On arrival subject's nude body mass (kg) and urine osmolality (mOsmol·kg -1 H 2 O) (Advanced Model 3320 Micro-Osmometer, Advanced Instruments, Inc., USA) were assessed.
A urine osmolality of ≤700 mOsmol·kg -1 H 2 O was used to verify pre and post-trial euhydration status (8) . Subjects drank 100 ml of cold water (4 °C) to verify the positioning of Reliability of intestinal temperature 8 the telemetry pill in the gastrointestinal tract. We observed changes in pill temperature greater than 0.1 °C for two subjects; in these instances tests were rescheduled. For all trials there was no change in pill temperature greater than 0.03 °C following cold water ingestion. After these initial measures, subjects rested for 60 min in the environmental chamber which was set at 35 °C, 50% RH to stabilise intestinal and skin temperature before commencing exercise. At rest and during exercise, subjects were encouraged to drink room temperature water (35 °C) to meet their individual fluid requirements. Measures of heart rate (HR), skin temperature (T sk ), intestinal temperature (T int ), RPE and thermal perception were recorded immediately prior to exercise (0 min) and at 5-min intervals throughout the exercise trial. The exercise test was terminated when one of the following criteria was met: 1) subjects voluntarily stopped exercising, 2) when intestinal core temperature reached 39.5 °C or 3) subjects completed 60 min of exercise.
Intestinal temperature
Intestinal temperature was assessed using a telemetric monitoring system consisting of an ingestion time has been reported to be sufficient to allow the telemetry pill to pass into the gastrointestinal tract and produce valid intestinal temperature measurements (13) .
Skin temperature
Four skin thermistors (Grant Instruments, Cambridge, UK) were attached to the left side of the body at the medial calf, anterior mid-thigh, anterior mid-forearm and chest using acrylic dressing (Tegaderm, 3M Healthcare, USA) and secured in place using hypoallergenic surgical tape (Transpore, 3M Healthcare, USA). Weighted mean skin temperature (T sk ) was calculated using the equation of Ramanathan (34) . Mean body temperature (T body ) was 
Statistical analysis
Reliability of gastrointestinal temperature, which in this study refers to the reproducibility of day-to-day measurements at identical time-points during exercise, was assessed through a number of statistical analyses following the guidelines of Atkinson and Nevill (3).
Bland-Altman plots (4) were generated to investigate systematic and random error trends.
The presence or absence of heteroscedasticity was formally investigated by plotting a regression line through the data points of the Bland-Altman plots. A paired t-test was used to assess systematic bias between trials, with statistical significance set at P ≤ 0. and large (0.8) effects (10) . A paired t-test was used to assess between trial differences in environmental conditions, urine osmolality, skin temperature, sweat rate, fluid intake and heart rate. Statistical significance was set at P ≤ 0.05. Gaussian distribution of data was assessed using Kolmogorov-Smirnov test and was accepted when P ≥ 0.05.
We acknowledge that practitioners prefer to use different approaches when assessing reliability and that the acceptable levels of error may differ between researchers. Therefore we have presented a range of reliability statistics and avoided using stringent and pre-defined acceptable levels of error. To provide real-world practical context to reliability data we present hypothetical changes in intestinal temperature (when used in a comparison study is an approach used to determine the effectiveness of a treatment) and used the approach of
Hopkins (21) to interpret magnitudes of change. This analysis determined the chance (probability) that a change was harmful, trivial or beneficial in context to the error (reliability) of the test and smallest worthwhile change. It also enabled identification of the minimum change in intestinal temperature that is deemed to be a likely-beneficial change (76% probability), which in the example was a decrease in intestinal temperature. and trial 2 to 0.84 ± 0.52%, which were not significantly different (P = 0.87). Heart rate and skin and body temperatures progressively increased throughout the heat trials reaching peak values at the end of exercise as evidenced in table 1. There was no statistically significant difference in mean heart rate between trial 1 and trial 2 (P = 0.97).
RESULTS
INSERT
Mean intestinal temperature after 60 min of exercise (table 2) indicates that the intensity and duration of exercise was sufficient to induce moderate-to-high levels of heat stress in both trials. The mean intestinal temperature bias between trial 1 and 2 was -0.07 ± 0.31 °C indicating a small but statistically significant systematic bias (P = 0.02). Visual inspection of figure 1 illustrates that intestinal temperature in trial 2 was consistently higher than trial 1 from 10 min onwards until termination of exercise.
INSERT Reliability data for the entire trial and each 10-min segment of the trial can be found in table 3. Using data from the entire set indicates good overall reliability for all statistical methods. However, when data was grouped by time (table 3) small changes in error were evident over the exercise duration. The error displays a trend that increases from the onset of exercise, before peaking mid-exercise and decreasing towards the end of exercise.
INSERT TABLE 3 HERE
As the Bland-Altman plot suggested the presence of heteroscedasticity, the coefficient of variation (which assumes the largest test-retest error occur at higher values) was used to determine probabilities of a change in intestinal temperature in relation to the smallest worthwhile change using the approach of Hopkins (21) (Table 4 ). This analysis suggests that a change in intestinal temperature as a result of a treatment or intervention (e.g. cooling) of 0.34 °C is required to be interpreted as a likely beneficial change (≥76% chance).
INSERT TABLE 4 HERE
Discussion
The main finding of this study is that the measurement of intestinal temperature using intestinal telemetry pills demonstrated good test-retest reliability during submaximal recumbent cycling exercise in the heat. In accordance with recommendations suggested by intestinal temperature is 0.5 °C there is an 88%, likely probable chance that this is a beneficial change and a 4%, very unlikely chance it is a harmful change. In this example, a decrease in core temperature may not always be a true decrease when considering the magnitude of change in context to the error of the system and smallest worthwhile change. It should be noted that to improve confidence in interpretation a smaller error (better reliability) would be required.
We observed a systematic error of -0.07 °C and LOA (95%) ± 0.61 °C which is lower than the mean bias of 0.30 °C and LOA (95%) of ± 1.2 °C reported by Goosey-Tolfrey et al. (18) despite a similar intensity of exercise, duration and environmental conditions in both studies.
The differences may be explained by a smaller sample size (n = 5) and a large variation in intestinal temperature of one subject in the Goosey-Tolfrey et al. (18) A potential explanation for the increased variation in intestinal temperature might be gastrointestinal (GI) function. The GI tract is a complex organ and the many potential interactions within it could serve to increase the variability observed in GI pill temperature in heat stressed humans. The recommended pill ingestion time of 6 hours prior to intestinal temperature measurement reflects a balance between sensor gastric emptying and expulsion time (5). We observed no changes in pill temperature greater than 0.03 °C when subjects ingested 100 ml of cold water 1 hour prior to exercise, confirming that the pill ingestion time of 6 hours provided sufficient time for gastric emptying. However, 2 tests out of 24 were rescheduled due to a change in observed pill temperature of greater than 0.1 °C. Wilkinson et al. (37) demonstrated that drinking cold water (5 -8 °C) influenced pill temperature by up to 2 °C 8 hours after pill ingestion. The authors suggested that this temperature variation may be due to the pill residing in areas of the GI tract in close proximity to the stomach (e.g. duodenum and transverse colon). To reduce the potential for pill temperature fluctuations in the present study, subjects ingested room temperature water (35 °C) at frequent intervals throughout the trial and as a result we observed no large variations in intestinal temperature.
In a further attempt to standardise GI function the subjects refrained from food three hours prior to each test and their diet was replicated in the preceding 24 hours. However, exercise speeds intestinal peristaltic velocity (36) and it is conceivable that peristaltic velocity might have been different between trials. Subsequently, this variation could have changed the position of the pill within the GI tract. Indeed, we observed an increase in temperature variability mid-exercise. As eluded to by Gant et al. (16) , this mid-exercise variability may have been caused by peristalsis advancing the pill along the GI tract before reaching more compact faecal matter towards the end of exercise, thereby reducing temperature variability.
Several human studies provide indirect evidence to support the notion of a temperature gradient along the GI tract as GI pill temperature is consistently higher than rectal temperature (5). Further evidence is available from animal studies which demonstrate a temperature gradient along with GI tract as duodenum and ilium temperatures were significantly higher than stomach, large intestine and rectum (19) . As a result one possible explanation for the observed variation in intestinal temperature is that variability in intestinal peristaltic velocity advances the pill to areas of the GI tract which may exhibit different temperatures. This interpretation suggests that although a pill ingestion time of 6 hours prior to exercise is sufficient for gastric emptying, perhaps a longer period is required to limit the effects of peristaltic velocity.
Several studies have presented data indicating that each pill has a bias from certified thermometry; as such it is recommended that each pill is individually calibrated. Following the recommendations by Hunt and Stewart (22), we noted excellent agreement (-0.01 ± 0.09 °C) between a verified electronic thermometer and intestinal pills. This agreement was similar to that reported within previous studies (7, 22, 37) and within the guidelines set by Moran and Mendel (30) who suggest random errors between thermometers should not be greater than ± 0.1 °C. To reduce potential systematic and random bias we applied a linear regression equation to each pill determined following verification. Therefore it is unlikely that the variation in intestinal temperature during exercise was due to invalid temperature measurement by the pills. Furthermore, the variation in intestinal temperature was not likely caused by a difference in total work between the two trials as there was no statistically significant difference between trials for mean HR (P = 0.97).
Our findings are only applicable to pill ingestion times of 6 hours. It is likely that different ingestion times will change pill location in the GI tract and influence reliability of the method.
Although skin temperature, thermal perception and RPE were high, mean end-exercise intestinal temperature was ≈38.60 ± 0.4 °C, which is around 1 -1.5 °C lower than reported voluntary exercise termination core temperature. As such our results should be applied with caution to temperatures exceeding 39 °C; however, during self-paced exercise, which is common in most sports, intestinal temperature may be regulated around 39 °C (31) . We also applied pill-specific regression equations to account for bias, and as such our findings might only be applicable after corrections have been employed. We recommend following the verification guidelines of Hunt and Stewart (22) prior to dispensing telemetry pills for ingestion as conducted in the present study. Recumbent cycling was chosen as the mode of exercise as laser-Doppler flowmetry, which requires a stable upper body, was used to assess forearm skin blood flow (data not presented). Generalisations to other modes of exercise should be applied with caution; however, it is likely that our results are applicable to other modes of exercise that produce similar energetic and thermoregulatory demands.
Practical Applications
We have assessed the reliability of intestinal temperature sensors using a range of statistical approaches and practitioners are encouraged to interpret these results using their preferred 
